Tiziana Life Sciences Ltd
TLSA | NASDAQ
$0.62
-$0.02 (-2.82%)
At close: Nov 5, 2026, 4:00 PM ET
$0.62
$0.00 (+0.53%)
After-hours:
Nov 5, 2026, 4:22 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Mar 31, 2022 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 304K | 234K | 149K | 187K | 167K | -10.92K | 4.62K | 700 | -55.84K | 77.77K | 123.47K |
Gross Profit | -304K | -234K | -149K | -187K | -167K | -96K | -111.54K | -700 | 55.84K | -77.77K | -123.47K |
Operating Income | -23.75M | -21.28M | -18.15M | -22.08M | -19.12M | -21.11M | -27.22M | -17.86M | -10.72M | -26.42M | -46.6M |
Interest Income | 14K | 19K | 707K | 926K | 1.38M | 1.15M | n/a | n/a | n/a | n/a | 7.83K |
Pretax Income | -25.19M | -18.43M | -14.4M | -24.73M | -24.59M | -19.54M | -24.29M | -18.86M | -10.31M | -22.31M | -41.16M |
Net Income | -25.19M | -18.43M | -12.84M | -16.52M | -18.38M | -19.99M | -24.29M | -18.86M | -8.69M | -20.69M | -38.91M |
Selling & General & Admin | 9.98M | 10.77M | 12.1M | 14.09M | 8.97M | -363.8K | 3.8M | 68.44K | -3.99M | 16.56M | 20.8M |
Research & Development | 13.47M | 10.28M | 5.9M | 7.81M | 9.98M | 8.99M | 10.91M | 15.81M | 12.78M | 9.77M | 8.85M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 12.5M | 12.5M | 1.98M | -965.6K | -2.95M | 16.82M |
Operating Expenses | 23.45M | 21.05M | 18M | 21.89M | 18.95M | 21.12M | 27.22M | 17.86M | 7.83M | 23.39M | 46.47M |
Interest Expense | 18K | 18K | 6K | 6K | 5K | 11.33K | 14.93K | 8.6K | 55.83 | 25.05K | 343.6K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.75M | 21.28M | 18.15M | 22.08M | 19.12M | 21.11M | 27.22M | 17.86M | 7.77M | 23.47M | 46.6M |
Income Tax Expense | n/a | n/a | -1.56M | -8.21M | -6.2M | 449K | n/a | n/a | n/a | n/a | -2.24M |
Shares Outstanding (Basic) | 63.94M | 59.47M | 58.41M | 54.56M | 51.55M | 51.33M | 50.76M | 50.29M | 50.76M | 110.82M | 75.11M |
Shares Outstanding (Diluted) | 63.94M | 59.47M | 58.41M | 54.56M | 51.55M | 51.33M | 50.76M | 50.29M | 50.76M | 110.82M | 75.11M |
EPS (Basic) | -0.42 | -0.32 | -0.22 | -0.32 | -0.36 | -0.38 | -0.48 | -0.38 | -29 | -29.14 | -0.48 |
EPS (Diluted) | -0.42 | -0.32 | -0.22 | -0.32 | -0.36 | -0.38 | -0.48 | -0.38 | -29 | -29.14 | -0.48 |
EBITDA | -23.45M | -17.73M | -14.24M | -24.6M | -24.48M | -19.43M | -24.17M | -18.8M | -10.67M | -26.34M | -46.47M |
EBIT | -23.75M | -17.96M | -14.39M | -24.72M | -24.58M | -19.53M | -24.27M | -18.85M | -10.68M | -26.42M | -46.6M |
Depreciation & Amortization | 304K | 234K | 149K | 124K | 104K | 96K | 101K | 51K | 7.5K | 80.27K | 123.47K |
Add to Watchlist
Select watchlists to add or remove TLSA